OOIR: Observatory of International Research

Papers

(The TQCC of European Respiratory Review is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Sex and gender in asthma	180
The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies	159
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management	141
Post-acute COVID-19 syndrome	137
COVID-19 pneumonia: pathophysiology and management	96
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea	94
Clinical significance and applications of oscillometry	88
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes	72
Bidirectional relationships of comorbidity with obstructive sleep apnoea	71
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries	70
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	69
Asthma and COVID-19: an update	63
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD	62
Diagnosis, course and management of hypersensitivity pneumonitis	57
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	56
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy	55
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe	55
Chronic cough: new insights and future prospects	53
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	53
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	52
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	50
Lung cancer is also a hereditary disease	49
Sex and gender in pulmonary arterial hypertension	46
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	45
Lung transplantation for interstitial lung disease	44

Just breathe: a review of sex and gender in chronic lung disease	44
Update on biology and management of mesothelioma	43
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review	43
Recent developments in the treatment of small cell lung cancer	43
Pulmonary hypertension phenotypes in patients with systemic sclerosis	41
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women	41
Management of tracheo-oesophageal fistula in adults	40
Eosinophils and eosinophilic immune dysfunction in health and disease	39
Current evidence for COVID-19 therapies: a systematic literature review	38
Systematic review and meta-analysis of residential radon and lung cancer in never-smokers	38
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects	37
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	37
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis	37
Influenza vaccination: protecting the most vulnerable	37
Contemporary issues in the implementation of lung cancer screening	36
Sex and gender in respiratory physiology	36
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	36
Post-intubation subglottic stenosis: aetiology at the cellular and molecular level	35
Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis	35
The clinical value of cardiopulmonary exercise testing in the modern era	34
Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research	34
Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis	34
Extracellular matrix remodelling in COPD	34
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis	33
Development and clinical translation of tubular constructs for tracheal tissue engineering: a review	33
The prevalence and related factors of fatigue in patients with COPD: a systematic review	33
Exercise training for lung transplant candidates and recipients: a systematic review	32
Genetic disorders of the surfactant system: focus on adult disease	32
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	31
Sex, gender and the pulmonary physiology of exercise	31
Cystic fibrosis-related diabetes and lung disease: an update	31
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives	31
Structure and function of small airways in asthma patients revisited	30
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis	30
The role of mucin 1 in respiratory diseases	30
Ventilatory efficiency in pulmonary vascular diseases	30
Exploring the 175-year history of spirometry and the vital lessons it can teach us today	30
Severe community-acquired pneumonia	29
Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people	28
Current unmet needs and potential solutions to uncontrolled asthma	28
Therapeutic bronchoscopy for central airway diseases	28
Chronic lung diseases: entangled in extracellular matrix	28
Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis	27
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	27
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic	27
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	27
The role of smoking in COVID-19 progression: a comprehensive meta-analysis	27
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure	26
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease	26
Sex and gender in interstitial lung diseases	26

Asthma-COPD overlap: current understanding and the utility of experimental models	26
Identifying risk factors for COPD and adult-onset asthma: an umbrella review	26
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	26
Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis	25
Holy Grail: the journey towards disease modification in asthma	25
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments	25
Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?	24
Meta-analysis on short-term exposure to ambient ultrafine particles and respiratory morbidity	24
Pulmonary aspergillosis: diagnosis and treatment	24
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	24
Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis	24
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	24
Waterpipe smoking: a review of pulmonary and health effects	23
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives	23
Minute ventilation/carbon dioxide production in patients with dysfunctional breathing	23
Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis	23
Diagnostic workup of childhood interstitial lung disease	23
Role of inhaled antibiotics in the era of highly effective CFTR modulators	23
Pulmonary alveolar microlithiasis	23
New bronchoscopic treatment modalities for patients with chronic bronchitis	22
The 6-min walk test as a primary end-point in interstitial lung disease	22
Interstitial pneumonia with autoimmune features: challenges and controversies	22
Hermansky–Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease	21
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health	21
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents	21
Circulating tumour cells in patients with lung cancer universally indicate poor prognosis	21
Natural variability in the disease course of SSc-ILD: implications for treatment	21
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?	20
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	20
Respiratory viruses: their importance and lessons learned from COVID-19	20
Recent advances in the management of pulmonary hypertension with interstitial lung disease	20
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	20
Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives	20
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	20
Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms	20